Menu

Varex Imaging Corporation VREX

Full chart Compare
Set alert

Price alert · VREX

All alert types
18.44 USD 0.00 (+0.00%)

At closeNov 9, 2026, 7:32 AM EST

18.42 -0.02 -0.08%

Pre-market · Nov 9, 7:32 AM ET

18.44 Day range 18.46
9.09 52-week range 18.63
YTD
+58.28%
1 year
+55.09%
Market cap
783.03M
Revenue (ttm)
832.70M
Profit margin
4.11%
EPS (ttm)
0.53
Shares out
41.10M
P/E ratio
34.79
Forward P/E
21.27
YTD return
+58.28%
1-year return
+55.09%
Volume
467.38K
Avg volume
922.64K
Open
18.44
Previous close
18.44
Day's range
18.44 – 18.46
52-week range
9.09 – 18.63
Beta
0.54
Price target
22.20 (+20.4%)
Earnings date
Feb 4, 2025

5D 0.00 (0.00%)

18.4518.5018.55MonTueWedThuFri18.44

Key statistics

Enterprise value
889.90M
PEG ratio
0.00
Price / sales
0.70
Price / book
1.00
Dividend yield
0.00%
Payout ratio
0.00%
Revenue growth
-9.90%
Free cash flow
53.21M
Total cash
190.00M
Total debt
470.30M
Return on equity
6.09%
Short % of float
5.81%
50-day average
14.30
200-day average
14.46

Financials — quick view

All financials
VREX Revenue — quarterly 210.50M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
VREX Net income — quarterly 15.70M
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026
VREX EPS — quarterly 0.37
2022-Q4 20222023-Q1 20222023-Q2 20232023-Q3 20232023-Q4 20232024-Q1 20232024-Q2 20242024-Q3 20242024-Q4 20242025-Q1 20242025-Q2 20252025-Q3 20252025-Q4 20252026-Q1 20252026-Q2 20262026-Q3 2026

Earnings

VREX recent earnings
Report dateQuarter endingEPS estimateEPS reportedSurpriseSurprise %
Feb 4, 2025Dec 1, 20240.04———
Nov 19, 2024Sep 1, 20240.100.19+0.09+90.00%
Aug 1, 2024Jun 1, 20240.190.14-0.05-26.32%
May 2, 2024Mar 1, 20240.230.16-0.07-30.43%
Feb 6, 2024Dec 1, 20230.110.06-0.05-45.45%
Nov 14, 2023Sep 1, 20230.330.45+0.12+36.36%

Upgrades / downgrades

VREX analyst upgrades and downgrades
DateFirmActionFromTo
Aug 23, 2024B. Riley Securitiesinit—Buy
Nov 15, 2023OppenheimermainOutperformOutperform
Aug 2, 2023OppenheimerreitOutperformOutperform
May 24, 2023JefferiesmainHoldHold
Oct 12, 2022Jefferiesinit—Hold
Feb 5, 2021OppenheimerupPerformOutperform

About Varex Imaging Corporation

Varex Imaging Corporation designs, manufactures, and sells X-ray imaging components. The company operates through two segments, Medical and Industrial. The Medical segment designs, manufactures, sells, and services X-ray imaging components, comprising X-ray tubes, digital detectors and accessories, ionization chambers, high voltage connectors, image-processing software and workstations, 3D reconstruction software, computer-aided diagnostic software, collimators, automatic exposure control devices, generators, and heat exchangers. This segment's products are used in a range of applications, including CT, mammography, oncology, cardiac, surgery, dental, and other diagnostic radiography uses. The Industrial segment designs, develops, manufactures, sells, and services Linatron X-ray linear accelerators, X-ray tubes, digital detectors, high voltage connectors, and coolers for use in security and inspection applications, such as baggage screening at airports, cargo screening at ports and borders, and nondestructive testing, irradiation, and inspection in various applications. The company sells its products through imaging system original equipment manufacturers, independent service companies, and distributors, as well as directly to end-users. It has operations in North America, South America, Europe, Russia, the Middle East, India, Africa, Asia, and Australia. Varex Imaging Corporation was incorporated in 2016 and is headquartered in Salt Lake City, Utah.

Sector
Healthcare
Industry
Medical Devices
Country
United States

News

Your note

Sign in to keep a note on VREX — it syncs with the Stock Master app.

Insider holders

VREX insider holders
InsiderRelationLatest transactionDateShares held
CHERTOFF JOCELYN D.DirectorConversion of Exercise of derivative securityFeb 8, 202427,138
GUERTIN TIMOTHY EDirectorConversion of Exercise of derivative securityFeb 8, 202411,721
HARTMANN ANDREWOfficerConversion of Exercise of derivative securityDec 9, 202424,177
HONEYSETT KIMBERLEY E.OfficerConversion of Exercise of derivative securityDec 9, 20244,865
JONAITIS MARK S.OfficerConversion of Exercise of derivative securityDec 9, 202465,241
KUNKEL JAY K.DirectorConversion of Exercise of derivative securityFeb 8, 202418,479

Institution ownership

VREX institution ownership
Holder% heldSharesValueReported
Blackrock Inc.9.53%3,928,83155.99MSep 29, 2024
Pzena Investment Management Llc9.44%3,890,87955.45MSep 29, 2024
Vanguard Group Inc8.45%3,483,60849.64MSep 29, 2024
Allspring Global Investments Holdings, LLC6.20%2,554,82336.41MSep 29, 2024
Cooke & Bieler LP5.52%2,277,40332.45MSep 29, 2024
Dimensional Fund Advisors LP5.44%2,242,04831.95MSep 29, 2024

Fund ownership

VREX fund ownership
Holder% heldSharesValueReported
Allspring Special Small Cap Value Fund4.22%1,740,63824.80MOct 30, 2024
Vanguard Total Stock Market Index Fund3.14%1,292,73618.42MSep 29, 2024
iShares Russell 2000 ETF2.40%988,27314.08MOct 30, 2024
Vanguard Extended Market Index Fund1.57%646,1909.21MSep 29, 2024
DFA U.S. Small Cap Value Series1.55%640,2939.12MJul 30, 2024
Vanguard Small-Cap Index Fund1.24%512,6407.31MSep 29, 2024